Network meta-analysis of 716 short-term double-blind trials (159 362 participants): versus placebo, CCBs (OR 1.43), ACE inhibitor+CCB and β-blocker+thiazide raised discontinuation for adverse events; ARBs (OR 0.73) and ARB+CCB (OR 0.61) lowered it.
Meta-analysisn = 159,362
Wang et al. Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-Analysis